This product is an unconjugated anti-Human Complement Factor B Bb Monoclonal antibody (CTJS-134) generated from the Mouse. The antibody can be used for EIA.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Clonality | Monoclonal |
| Clone | CTJS-134 |
| Host Animal | Mouse |
| Isotype | IgG2a κ |
| Immunogen | Purified human complement Factor B |
| Species Reactivity | Human |
| Applications | EIA |
| Application Notes | EIA: 1:2500 The optimal working dilutions should be determined by the end user. |
| Specificity | This antibody reacts with Human Complement Factor B Bb. |
| Purity | ≥95% as determined by SDS-PAGE |
| Conjugation | Unconjugated |
| Format | Liquid |
| Size | 100 µL |
| Storage | Store at 4°C for short term. Store at -20°C for long term. Avoid freeze-thaw cycle. |
| Type | Primary Antibody |
| Target Name | Factor Bb |
| Alternative Names | Complement Factor Bb; Complement Factor Bb fragment; Factor Bb fragment; CF Bb |
| Gene ID | 629 |
| UniProt ID | P00751 |
| Introduction | Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B-lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes. |